FdaApplication
NDA 209670
Identifiers
- fda_app_no: NDA209670
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMS INC |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | 50MG;300MG;300MG | TABLET;ORAL |
1 product